Comparison of persistence rates between allopurinol and febuxostat as first-line urate-lowering therapy in patients with gout: an 8-year retrospective cohort study

被引：0
|
作者：
Aran Kim
Yunkyung Kim
Geun-Tae Kim
Eunyoung Ahn
Min Wook So
Seung-Geun Lee
机构：
[1] Pusan National University Hospital,Division of Rheumatology, Department of Internal Medicine
[2] Pusan National University School of Medicine,Biomedical Research Institute
[3] Pusan National University Hospital,Division of Rheumatology, Department of Internal Medicine
[4] Kosin University College of Medicine,Division of Rheumatology, Department of Internal Medicine
[5] Pusan National University Yangsan Hospital,undefined
来源：
Clinical Rheumatology | 2020年 / 39卷
关键词：
Allopurinol; Febuxostat; Gout; Medication adherence; Patient compliance; Uric acid;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3769 / 3776
页数：7
相关论文
共 50 条
  • [1] Comparison of persistence rates between allopurinol and febuxostat as first-line urate-lowering therapy in patients with gout: an 8-year retrospective cohort study
    Kim, Aran
    Kim, Yunkyung
    Kim, Geun-Tae
    Ahn, Eunyoung
    So, Min Wook
    Lee, Seung-Geun
    CLINICAL RHEUMATOLOGY, 2020, 39 (12) : 3769 - 3776
  • [2] COMPARISON OF URATE-LOWERING EFFICACY AND SAFETY OF FEBUXOSTAT AND ALLOPURINOL IN GOUT PATIENTS
    Singh, Gajendera
    Kumar, Hemant
    Soni, Udit
    Tyagi, Shikhar
    Aggarwal, Kritika
    Verma, Kavita
    Kumar, Sumit
    HETEROCYCLIC LETTERS, 2016, 6 (01): : 133 - 147
  • [3] Outcome Of Allopurinol Or Febuxostat Treatment In Gout Patients Naive To Urate-Lowering Therapy
    Khanna, Puja
    Hatoum, Hind
    Lin, Swu-Jane
    Shiozawa, Aki
    Akhras, Kasem
    Khanna, Dinesh
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S857 - S857
  • [4] The aftermath of Urate-Lowering TheRApy in gout (ULTRA) registry: The first prospective observational multicenter cohort of Korean patients with gout
    Moon, Ki Won
    Kim, Min Jung
    Shin, Kichul
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2023, 26 (06) : 1015 - 1018
  • [5] Effects of intensive urate lowering therapy with febuxostat in comparison with allopurinol on pulse wave velocity in patients with gout and increased cardiovascular risk: the FORWARD study
    Desideri, Giovambattista
    Rajzer, Marek
    Gerritsen, Martijn
    Nurmohamed, Michael T.
    Giannattasio, Cristina
    Tausche, Anne-Kathrin
    Borghi, Claudio
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2022, 8 (03) : 236 - 242
  • [6] Atrial Fibrillation Risk and Urate-Lowering Therapy in Patients with Gout: A Cohort Study Using a Clinical Database
    Liu, Ching-Han
    Huang, Shih-Chung
    Yin, Chun-Hao
    Huang, Wei-Chun
    Chen, Jin-Shuen
    Chen, Yao-Shen
    Gan, Su-Ting
    Tzou, Shiow-Jyu
    Hsu, Ching-Tsai
    Wu, Hao-Ming
    Wang, Wen-Hwa
    BIOMEDICINES, 2023, 11 (01)
  • [7] As compared to allopurinol, urate-lowering therapy with febuxostat has superior effects on oxidative stress and pulse wave velocity in patients with severe chronic tophaceous gout
    Tausche, A. -K.
    Christoph, M.
    Forkmann, M.
    Richter, U.
    Kopprasch, S.
    Bielitz, C.
    Aringer, M.
    Wunderlich, C.
    RHEUMATOLOGY INTERNATIONAL, 2014, 34 (01) : 101 - 109
  • [8] As compared to allopurinol, urate-lowering therapy with febuxostat has superior effects on oxidative stress and pulse wave velocity in patients with severe chronic tophaceous gout
    A.-K. Tausche
    M. Christoph
    M. Forkmann
    U. Richter
    S. Kopprasch
    C. Bielitz
    M. Aringer
    C. Wunderlich
    Rheumatology International, 2014, 34 : 101 - 109
  • [9] The safety and urate-lowering efficacy of febuxostat in patients undergoing peritoneal dialysis: a retrospective single-arm cohort study of 84 patients
    Ma, Jianwei
    Huang, Jiancheng
    Bao, Sizeng
    Zhang, Aiwei
    Dai, Lili
    Yu, Qiang
    Bian, Xueyan
    ANNALS OF PALLIATIVE MEDICINE, 2022, 11 (07) : 2443 - 2450
  • [10] ADHERENCE TO URATE-LOWERING THERAPY IN PATIENTS WITH SEVERE GOUT WHO RECEIVED CANAKINUMAB FOLLOWING A 5-YEAR RETROSPECTIVE ANALYSIS
    Eliseev, M.
    Sheliabina, O.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 445 - 446
12345